Gentex Corp (GNTX) shareholders
Close on Nov 17, 2026Market cap $3.96BP/E 9.9Yield 2.55%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 20,726,451 | 8.90% | 13G (passive) amendment | Dec 31, 2023 |
| Wellington Management Group LLP Joint filing with Wellington Group Holdings LLP (6.00%), Wellington Investment Advisors Holdings LLP (6.00%) and 1 more | 13,444,917 | 6.00% | 13G (passive) amendment | Jun 30, 2025 |
| Vanguard Capital Management | 11,377,317 | 5.28% | 13G (passive) | Mar 31, 2026 |
| American Century Companies, Inc. Joint filing with American Century Investment Management, Inc. (5.20%), Stowers Institute for Medical Research (5.20%) | 11,025,677 | 5.20% | 13G (passive) | Jun 30, 2026 |
| Dimensional Fund Advisors LP | 10,550,621 | 5.00% | 13G (passive) | Sep 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of GNTX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 21,776,286 | 10.34% | $550.29M | +478,104 | 0.01% |
| American Century Companies Inc | 11,025,677 | 5.23% | $278.62M | +422,341 | 0.12% |
| Vanguard Portfolio Management LLC | 10,292,975 | 4.89% | $260.10M | +33,725 | 0.01% |
| Vanguard Capital Management LLC | 9,611,028 | 4.56% | $242.87M | −90,313 | 0.01% |
| Dimensional Fund Advisors LP | 9,032,475 | 4.29% | $228.25M | +1,569,176 | 0.04% |
| Ariel Investments, LLC | 8,309,786 | 3.94% | $209.99M | −32,616 | 2.09% |
| Fuller & Thaler Asset Management, Inc. | 8,112,203 | 3.85% | $205.00M | +1,003,524 | 0.56% |
| Bank Of Montreal /Can/ | 7,339,694 | 3.48% | $185.47M | −58,315 | 0.06% |
| State Street Corp | 7,166,474 | 3.40% | $181.10M | +85,375 | 0.01% |
| Geode Capital Management, LLC | 6,178,116 | 2.93% | $156.15M | +168,369 | 0.01% |
| Boston Partners | 5,743,184 | 2.73% | $145.10M | +53,148 | 0.13% |
| Disciplined Growth Investors Inc /Mn | 4,561,485 | 2.17% | $115.27M | +41,777 | 1.95% |
| Goldman Sachs Group Inc | 4,061,493 | 1.93% | $102.63M | +286,253 | 0.01% |
| Arrowstreet Capital, Limited Partnership | 3,472,847 | 1.65% | $87.76M | +477,803 | 0.04% |
| Caisse De Depot Et Placement Du Quebec | 3,162,808 | 1.50% | $79.92M | −677,144 | 0.11% |
| Morgan Stanley | 3,032,438 | 1.44% | $76.63M | −14,224 | 0.00% |
| Charles Schwab Investment Management Inc | 2,386,873 | 1.13% | $60.32M | −51,001 | 0.01% |
| Seizert Capital Partners, LLC | 2,335,889 | 1.11% | $59.03M | +347,236 | 2.44% |
| Northern Trust Corp | 2,173,343 | 1.03% | $54.92M | +3,375 | 0.01% |
| UBS Group AG | 2,126,036 | 1.01% | $53.72M | +616,654 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 531 | 209M | 99.4% | 79 / 208 | 166 / 45 | 21M | 11M |
| Q1 2026 | 506 | 200M | 94.7% | 69 / 198 | 169 / 83 | 43M | 30M |
| Q4 2025 | 526 | 209M | 99.2% | 95 / 173 | 196 / 72 | 40M | 39M |
| Q3 2025 | 512 | 216M | 100.0% | 89 / 151 | 207 / 53 | 26M | 27M |
| Q2 2025 | 483 | 218M | 100.0% | 55 / 193 | 179 / 86 | 23M | 26M |
| Q1 2025 | 518 | 221M | 100.0% | 68 / 205 | 180 / 79 | 27M | 24M |
| Q4 2024 | 535 | 218M | 100.0% | 70 / 192 | 205 / 53 | 17M | 14M |
| Q3 2024 | 526 | 215M | 100.0% | 58 / 188 | 201 / 61 | 37M | 14M |
| Q2 2024 | 535 | 214M | 100.0% | 70 / 206 | 183 / 60 | 19M | 17M |
| Q1 2024 | 530 | 214M | 100.0% | 74 / 186 | 187 / 49 | 21M | 12M |
| Q4 2023 | 511 | 205M | 97.5% | 57 / 193 | 190 / 38 | 23M | 15M |
| Q3 2023 | 500 | 197M | 93.4% | 63 / 187 | 180 / 47 | 12M | 16M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
441 funds held GNTX in Q2 2026, 49% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of GNTX | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 7,290,500 | 3.46% | $184.23M | 0.15% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 6,750,759 | 3.20% | $170.59M | 0.01% | Jun 30, 2026 |
| Avantis U.S. Small Cap Value ETF | 5,045,305 | 2.39% | $121.89M | 0.45% | May 31, 2026 |
| Vanguard Small-Cap Index Fund | 4,885,492 | 2.32% | $123.46M | 0.07% | Jun 30, 2026 |
| Undiscovered Managers Behavioral Value Fund | 4,053,366 | 1.92% | $102.43M | 1.14% | Jun 30, 2026 |
| Disciplined Value Mid Cap Fund | 3,927,359 | 1.86% | $99.24M | 0.43% | Jun 30, 2026 |
| Ariel Fund | 3,239,417 | 1.54% | $81.86M | 2.83% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 2,819,207 | 1.34% | $71.24M | 0.15% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 2,439,569 | 1.16% | $61.65M | 0.06% | Jun 30, 2026 |
| Fullerthaler Behavioral Unconstrained Equity | 1,611,020 | 0.76% | $40.71M | 4.24% | Jun 30, 2026 |
| Equity Income Fund | 1,254,892 | 0.60% | $31.71M | 0.49% | Jun 30, 2026 |
| Mid Cap Value Fund | 1,248,754 | 0.59% | $31.56M | 0.56% | Jun 30, 2026 |
| U.S. Targeted Value Portfolio | 1,221,951 | 0.58% | $28.54M | 0.17% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 1,119,704 | 0.53% | $27.05M | 0.06% | May 31, 2026 |
| U.S. Small Cap Value Portfolio | 1,118,313 | 0.53% | $26.12M | 0.13% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Kevin C. Nash | Chief Financial Officer | 73,310 | 0.03% | Feb 19, 2026 |
| Matthew Chiodo | Vice President of Sales | 47,148 | 0.02% | Feb 19, 2026 |
| Scott P. Ryan | General Counsel | 55,279 | 0.03% | Feb 19, 2026 |
| Steven R. Downing | President and CEO | 255,162 | 0.12% | Feb 19, 2026 |
| Neil Boehm | Chief Technology Officer | 73,904 | 0.04% | Feb 19, 2026 |
| Billy Pink | Director | 15,329 | 0.01% | May 22, 2026 |
| Garth Deur | Director | 20,045 | 0.01% | May 22, 2026 |
| Richard O. Schaum | Director | 87,069 | 0.04% | May 22, 2026 |
| John C. Kennedy | Director | 0 | – | May 22, 2026 |
| Leslie L. Brown | Director | 41,988 | 0.02% | May 22, 2026 |
| Brian C. Walker | Director | 29,831 | 0.01% | May 22, 2026 |
| Kathleen Starkoff | Director | 36,770 | 0.02% | May 22, 2026 |
| Ling Zang | Director | 35,599 | 0.02% | May 22, 2026 |
| Joseph B. Anderson Jr | Director | 0 | – | May 15, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Ling Zang Director | May 21, 2026 | Award | +5,626 | – | – | 35,599 |
| John C. Kennedy Director | May 21, 2026 | Award | +5,626 | – | – | 5,626 |
| Brian C. Walker Director | May 21, 2026 | Award | +5,626 | – | – | 29,831 |
| Garth Deur Director | May 21, 2026 | Award | +5,626 | – | – | 20,045 |
| Kathleen Starkoff Director | May 21, 2026 | Award | +5,626 | – | – | 36,770 |
| Leslie L. Brown Director | May 21, 2026 | Award | +5,626 | – | – | 41,988 |
| Richard O. Schaum Director | May 21, 2026 | Award | +5,626 | – | – | 87,069 |
| Billy Pink Director | May 21, 2026 | Award | +5,626 | – | – | 15,329 |
| Joseph B. Anderson Jr Director | May 15, 2026 | Sale | −5,939 | $22.98 | $136.48K | 0 |
| Brian C. Walker Director | May 15, 2026 | Sale | −5,939 | $22.98 | $136.48K | 24,205 |
| Leslie L. Brown Director | May 5, 2026 | Option exercise | +7,000 | $18.70 | $130.90K | 47,144 |
| Leslie L. Brown Director | May 5, 2026 | Sale | −10,782 | $22.85 | $246.37K | 36,362 |
| Leslie L. Brown Director | May 5, 2026 | Option exercise | +7,000 | $15.74 | $110.18K | 40,144 |
| Richard O. Schaum Director | Apr 30, 2026 | Sale | −4,815 | $23.31 | $112.24K | 81,443 |
| Richard O. Schaum Director | Apr 30, 2026 | Option exercise | +7,000 | $15.74 | $110.18K | 86,258 |
| Kevin C. Nash Chief Financial Officer | Feb 19, 2026 | Award | +13,880 | – | – | 73,310 |
| Neil Boehm Chief Technology Officer | Feb 19, 2026 | Award | +14,953 | – | – | 73,904 |
| Matthew Chiodo Vice President of Sales | Feb 19, 2026 | Award | +12,047 | – | – | 47,148 |
| Steven R. Downing President and CEO | Feb 19, 2026 | Award | +43,492 | – | – | 255,162 |
| Scott P. Ryan General Counsel | Feb 19, 2026 | Award | +11,000 | – | – | 55,279 |
| Kevin C. Nash Chief Financial Officer | Feb 17, 2026 | Sale | −5,568 | $24.98 | $139.09K | 59,430 |
| Kevin C. Nash Chief Financial Officer | Feb 17, 2026 | Award | +38,181 | – | – | 92,485 |
| Kevin C. Nash Chief Financial Officer | Feb 17, 2026 | Tax withholding | −16,864 | $24.89 | $419.74K | 75,621 |
| Kevin C. Nash Chief Financial Officer | Feb 17, 2026 | Tax withholding | −4,306 | $24.89 | $107.18K | 71,315 |
| Kevin C. Nash Chief Financial Officer | Feb 17, 2026 | Sale | −6,317 | $24.98 | $157.80K | 64,998 |
| Neil Boehm Chief Technology Officer | Feb 17, 2026 | Sale | −2,332 | $24.82 | $57.88K | 58,951 |
| Neil Boehm Chief Technology Officer | Feb 17, 2026 | Award | +31,993 | – | – | 87,967 |
| Neil Boehm Chief Technology Officer | Feb 17, 2026 | Tax withholding | −14,160 | $24.89 | $352.44K | 73,807 |
| Neil Boehm Chief Technology Officer | Feb 17, 2026 | Sale | −8,916 | $24.82 | $221.30K | 64,891 |
| Neil Boehm Chief Technology Officer | Feb 17, 2026 | Tax withholding | −3,608 | $24.89 | $89.80K | 61,283 |
| Matthew Chiodo Vice President of Sales | Feb 17, 2026 | Tax withholding | −3,187 | $24.89 | $79.32K | 54,928 |
| Matthew Chiodo Vice President of Sales | Feb 17, 2026 | Tax withholding | −12,564 | $24.89 | $312.72K | 58,115 |
| Matthew Chiodo Vice President of Sales | Feb 17, 2026 | Sale | −15,705 | $25.03 | $393.10K | 39,223 |
| Matthew Chiodo Vice President of Sales | Feb 17, 2026 | Sale | −4,122 | $25.03 | $103.17K | 35,101 |
| Matthew Chiodo Vice President of Sales | Feb 17, 2026 | Award | +28,269 | – | – | 70,679 |
| Steven R. Downing President and CEO | Feb 17, 2026 | Sale | −35,000 | $24.75 | $866.25K | 211,670 |
| Steven R. Downing President and CEO | Feb 17, 2026 | Award | +124,311 | – | – | 315,002 |
| Steven R. Downing President and CEO | Feb 17, 2026 | Tax withholding | −54,314 | $24.89 | $1.35M | 260,688 |
| Steven R. Downing President and CEO | Feb 17, 2026 | Tax withholding | −14,018 | $24.89 | $348.91K | 246,670 |
| Scott P. Ryan General Counsel | Feb 17, 2026 | Tax withholding | −2,907 | $24.89 | $72.36K | 53,303 |
| Scott P. Ryan General Counsel | Feb 17, 2026 | Tax withholding | −11,492 | $24.89 | $286.04K | 56,210 |
| Scott P. Ryan General Counsel | Feb 17, 2026 | Sale | −7,145 | $24.73 | $176.70K | 46,158 |
| Scott P. Ryan General Counsel | Feb 17, 2026 | Sale | −1,879 | $24.73 | $46.47K | 44,279 |
| Scott P. Ryan General Counsel | Feb 17, 2026 | Award | +25,782 | – | – | 67,702 |
| Kevin C. Nash Chief Financial Officer | Aug 26, 2025 | Gift | −865 | $28.28 | $24.46K | 54,304 |
| Joseph B. Anderson Jr Director | May 16, 2025 | Sale | −3,764 | $22.87 | $86.08K | 5,939 |
| Billy Pink Director | May 15, 2025 | Award | +5,939 | – | – | 9,703 |
| Garth Deur Director | May 15, 2025 | Award | +5,939 | – | – | 14,419 |
| Kathleen Starkoff Director | May 15, 2025 | Award | +5,939 | – | – | 31,144 |
| Brian C. Walker Director | May 15, 2025 | Award | +5,939 | – | – | 30,144 |
| Richard O. Schaum Director | May 15, 2025 | Award | +5,939 | – | – | 79,258 |
| Leslie L. Brown Director | May 15, 2025 | Award | +5,939 | – | – | 33,144 |
| Ling Zang Director | May 15, 2025 | Award | +5,939 | – | – | 29,973 |
| Joseph B. Anderson Jr Director | May 15, 2025 | Award | +5,939 | – | – | 9,703 |
| Richard O. Schaum Director | May 1, 2025 | Option exercise | +7,000 | $17.46 | $122.22K | 73,319 |
| Steven R. Downing President and CEO | Feb 20, 2025 | Award | +37,725 | – | – | 189,623 |
| Neil Boehm Chief Technology Officer | Feb 20, 2025 | Award | +12,263 | – | – | 55,595 |
| Scott P. Ryan General Counsel | Feb 20, 2025 | Award | +8,370 | – | – | 40,852 |
| Matthew Chiodo Vice President of Sales | Feb 20, 2025 | Award | +9,130 | – | – | 41,342 |
| Kevin C. Nash Chief Financial Officer | Feb 20, 2025 | Award | +11,836 | – | – | 54,101 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Gentex's stock actually held short. Settlement fails (shares not delivered on time) peaked at 141,398 shares on Sep 11, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Leslie L. Brown Director | May 5, 2026 | 10,782 | $246.34K | May 5, 2026 | Stock Option Exercise |
| Richard O. Schaum Director | Apr 30, 2026 | 4,815 | $112.25K | Apr 30, 2026 | Stock Option Exercise |
| Neil Boehm Officer | Feb 17, 2026 | 11,248 | $279.18K | Feb 17, 2026 | Restricted stock vesting under a registered plan |
| Scott P. Ryan Officer | Feb 17, 2026 | 9,024 | $223.17K | Feb 17, 2026 | Restricted stock vesting under a registered plan |
| Matthew Chiodo Officer | Feb 17, 2026 | 19,827 | $496.17K | Feb 17, 2026 | Performance Stock Units |
| Steven R. Downing Officer | Feb 17, 2026 | 35,000 | $866.10K | Feb 17, 2026 | Performance Stock Units |
| Kevin C. Nash Officer | Feb 17, 2026 | 11,885 | $296.85K | Feb 17, 2026 | Performance Stock Units |
| Scott P. Ryan Officer | Feb 20, 2024 | 12,500 | $437.45K | Feb 20, 2024 | Stock Option Exercise |
| Kevin C. Nash Officer | Feb 20, 2024 | 13,500 | $473.09K | Feb 20, 2024 | Stock Option Exercise |
| Gary F. Goode Director | Feb 9, 2024 | 7,000 | $245.14K | Feb 9, 2024 | Stock Option Exercise |
| Gary F. Goode Director | Feb 2, 2024 | 7,000 | $238.79K | Feb 2, 2024 | Stock Option Exercise |
| Richard O. Schaum Director | Feb 1, 2024 | 6,022 | $204.33K | Feb 1, 2024 | Stock Option Exercise |
| Kathleen Starkoff Director | Jul 31, 2023 | 4,430 | $147.09K | Jul 31, 2023 | Stock Option Exercise |
| Joseph B. Anderson Jr Director | Jul 31, 2023 | 4,416 | $145.24K | Jul 31, 2023 | Vested Restricted Shares |
| Gary F. Goode Director | May 19, 2023 | 4,416 | $124.27K | May 19, 2023 | Restricted Shares Vesting |
Congress trades
3 trades in Gentex reported by 2 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Greg Gianforte MT00 · joint account | Sold (part) | Dec 20, 2018 | $50K | Jan 23, 2019 |
| Greg Gianforte MT00 · joint account | Bought | Aug 23, 2017 | $50K–100K | Sep 12, 2017 |
| Thomas MacArthur NJ03 · joint account | Sold | May 27, 2015 | $1K–15K | Jun 7, 2015 |
See a number that looks wrong?